A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies

Erstveröffentlichung
2019
Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors
Boettcher, Steffen
Miller, Peter G.
Sharma, Rohan
McConkey, Marie
Leventhal, Matthew
et al.
Institutions
UKU. Klinik für Innere Medizin III
Published in
Science ; 365 (2019), 6453. - S. 599+. - ISSN 0036-8075. - eISSN 1095-9203
Link to publication
https://dx.doi.org/10.1126/science.aax3649
Funding information
NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P01CA066996, P50CA206963, R01HL082945]
Howard Hughes Medical InstituteHoward Hughes Medical Institute
Edward P. Evans Foundation
Leukemia and Lymphoma SocietyLeukemia and Lymphoma Society
Adelson Medical Research Foundation
etc.
Keywords
MUTANT P53; CLONAL HEMATOPOIESIS; SOMATIC MUTATIONS; POINT MUTATIONS; GENE ONTOLOGY; K562 CELLS; BCR-ABL; GAIN; CANCER; EXPRESSION
Dewey Decimal Group
DDC 570 / Life sciences
DDC 610 / Medicine & health
Metadata
Show full item record